The GK5 activators presented here are not direct activators but are compounds that could potentially influence GK5 activity indirectly through modulation of metabolic pathways. GK5, being a part of the glycerolipid metabolism pathway, is influenced by the overall state of cellular metabolism, particularly glucose and lipid metabolism. Compounds like Insulin and Metformin are known to have profound effects on these metabolic pathways, which could in turn affect GK5 activity. Insulin, for instance, can enhance glycerol kinase activity in certain contexts by altering glucose and lipid metabolism, suggesting potential indirect effects on GK5. Additionally, compounds like Fructose-2,6-bisphosphate and AMP, which are key regulators of glycolysis and gluconeogenesis, might indirectly influence GK5 activity by altering the balance between these metabolic pathways. The role of cAMP in signaling pathways, as influenced by Forskolin, is another example of indirect modulation, where changes in cAMP levels could affect GK5 activity through a cascade of signaling events.
Furthermore, metabolic intermediates and supplements like Acetyl-L-carnitine and Nicotinamide riboside, and natural compounds such as Berberine, Omega-3 fatty acids, and Resveratrol, are involved in various aspects of metabolism. Their influence on lipid and energy metabolism could have secondary effects on GK5 activity. The impact of these compounds on GK5 is context-dependent and could vary with factors such as cell type, metabolic state, and the presence of other metabolic regulators. In summary, the potential GK5 activators listed here offer a perspective on how various compounds, primarily involved in regulating metabolic pathways, could indirectly affect GK5 activity. This indirect activation is reflective of the complex interplay between different metabolic routes and the multifaceted role of enzymes like GK5 within these pathways. These compounds, therefore, provide avenues for exploring the regulation and functional dynamics of GK5 in the context of broader metabolic processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Can enhance glycerol kinase activity by influencing glucose and lipid metabolism, potentially affecting GK5. | ||||||
Adenosine phosphate(Vitamin B8) | 61-19-8 | sc-278678 sc-278678A | 50 g 100 g | $160.00 $240.00 | ||
As an allosteric regulator in energy metabolism, it could modulate GK5 activity in response to cellular energy status. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
Known to modulate lipid metabolism, potentially influencing GK5 activity indirectly. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $42.00 $62.00 $153.00 $255.00 $500.00 $30.00 | 37 | |
Primarily targets hepatic gluconeogenesis but could have secondary effects on GK5 activity. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
As a PPAR-γ agonist, it affects lipid metabolism and may indirectly modulate GK5 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Increases cAMP levels, potentially influencing GK5 activity through cAMP-dependent signaling pathways. | ||||||
Nicotinamide riboside | 1341-23-7 | sc-507345 | 10 mg | $411.00 | ||
A NAD+ precursor, can influence metabolic pathways and potentially affect GK5 activity. | ||||||
Acetyl-L-carnitine chloride | 5080-50-2 | sc-210747 | 1 g | $52.00 | ||
Involved in fatty acid metabolism, could indirectly influence GK5 activity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Stimulates lipolysis and could indirectly influence GK5 by altering lipid metabolism. | ||||||